Gilder Gagnon Howe & Co’s Repligen RGEN Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4	Closed	-$566	–	297
2023 Q2	$566	Sell	4 -187,395	-100%	-$30M	﹤0.01%	329
2023 Q1	$31.6M	Sell	187,399 -2,968	-2%	-$530K	0.52%	49
2022 Q4	$32.2M	Sell	190,367 -1,123	-0.6%	-$204K	0.6%	47
2022 Q3	$35.8M	Sell	191,490 -28,093	-13%	-$5.92M	0.63%	48
2022 Q2	$35.7M	Sell	219,583 -3,267	-1%	-$517K	0.64%	48
2022 Q1	$41.9M	Sell	222,850 -217,715	-49%	-$41.4M	0.39%	72
2021 Q4	$117M	Sell	440,565 -11,571	-3%	-$3.12M	0.66%	47
2021 Q3	$131M	Sell	452,136 -13,865	-3%	-$3.56M	0.68%	48
2021 Q2	$93M	Sell	466,001 -1,898	-0.4%	-$368K	0.46%	64
2021 Q1	$91M	Sell	467,899 -12,726	-3%	-$2.61M	0.49%	63
2020 Q4	$92.1M	Sell	480,625 -2,328	-0.5%	-$424K	0.46%	67
2020 Q3	$71.3M	Sell	482,953 -11,999	-2%	-$1.72M	0.44%	72
2020 Q2	$61.2M	Sell	494,952 -19,314	-4%	-$2.27M	0.48%	65
2020 Q1	$49.6M	Sell	514,266 -18,664	-4%	-$1.8M	0.6%	63
2019 Q4	$49.3M	Buy	+532,930	New	+$44.8M	0.51%	69

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Gilder Gagnon Howe & Co's RGEN Position: Q3 2023 in Review

Gilder Gagnon Howe & Co sold out of Repligen (RGEN) in Q3 2023, closing a stake of 4 shares — an estimated $566 sold.

Gilder Gagnon Howe & Co first reported a position in RGEN in Q4 2019 and held it in 15 quarters. The position peaked at $131M in Q3 2021. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

Gilder Gagnon Howe & Co reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 4 Repligen shares in Q3 2023, an estimated $566.
Gilder Gagnon Howe & Co first reported a position in Repligen in Q4 2019 and held it in 15 quarters.
Gilder Gagnon Howe & Co's Repligen position peaked at $131M in Q3 2021.
439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2023, filed 14 Nov 2023.